ProfileGDS4095 / 238031_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 76% 77% 74% 76% 77% 76% 73% 74% 75% 74% 76% 74% 75% 74% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep17.9244876
GSM709769LY2 SRC1-siRNA tamoxifen treated rep38.2316577
GSM709765LY2 SRC1-siRNA untreated rep37.5683174
GSM709771LY2 SRC1-siRNA untreated rep18.1291376
GSM709772LY2 SRC1-siRNA untreated rep28.1749377
GSM709775LY2 SRC1-siRNA untreated rep48.1187176
GSM709764LY2 control-siRNA tamoxifen treated rep27.3536773
GSM709766LY2 control-siRNA tamoxifen treated rep37.7079974
GSM709768LY2 control-siRNA tamoxifen treated rep17.7710275
GSM709777LY2 control-siRNA tamoxifen treated rep47.5691674
GSM709770LY2 control-siRNA untreated rep38.0011576
GSM709773LY2 control-siRNA untreated rep17.7230674
GSM709774LY2 control-siRNA untreated rep27.7674475
GSM709776LY2 control-siRNA untreated rep47.535474